0001179110-22-000724.txt : 20220202
0001179110-22-000724.hdr.sgml : 20220202
20220202203616
ACCESSION NUMBER: 0001179110-22-000724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kurzius Lawrence Erik
CENTRAL INDEX KEY: 0001352090
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 22586044
MAIL ADDRESS:
STREET 1: 18 LOVETON CIRCLE
CITY: SPARKS
STATE: MD
ZIP: 21152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
FORM 4 -
X0306
4
2022-01-31
0
0001739104
Elanco Animal Health Inc
ELAN
0001352090
Kurzius Lawrence Erik
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
1
0
0
0
Deferred Stock Units
2022-01-31
4
A
0
352.0226
26.04
A
Common Stock
352.0226
9370.313
D
Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022.
/s/ Collin G. Smyser, as Attorney-in-Fact for Lawrence Kurzius
2022-02-02
EX-24
2
kurziuspoa.txt
POWER OF ATTORNEY
January 24, 2022
Know all by these present that the undersigned hereby constitutes and
appoints Marcela A. Kirberger, Collin G. Smyser, Brooke Aurs, Amy C. Seidel,
and Amra Hoso, with full power of substitution, the undersigned's true and
lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Elanco Animal Health
Incorporated (the "Company") or as a stockholder of the Company or as a
trustee of a stockholder of the Company, Forms 3, 4, and 5 and Schedules
13D or 13G, including amendments thereto, relating to the securities of
the Company in accordance with Section 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3,
4, or 5 or Schedule 13D or 13G, complete and execute any amendment or
amendments thereto, and timely file such form with the United States
Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of each such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by each
such attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as each such attorney-in-fact may approve in each such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that each such
attorney-in-fact, or each such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this Power of Attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with, or liabilities that may arise
under, Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 or Schedules 13D
or 13G with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.
This Power of Attorney shall not revoke any powers of attorney previously
executed by the undersigned. This Power of Attorney shall not be revoked by
any subsequent power of attorney that the undersigned may execute, unless such
subsequent power of attorney specifically provides that it revokes this Power
of Attorney by referring to the date of the undersigned's execution of this
Power of Attorney.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of the day and year first above written.
/s/ Lawrence Kurzius